Plasma
Promoted content

The socioeconomic benefits of plasma-derived medicines
Every year more people across the EU are diagnosed with life-threatening conditions which can only be treated with plasma-derived medicines.Promoted content

Facts about compensating plasma donors
The revision of the European Union Blood, Tissues and Cells (BTC) Legislation brings an opportunity to strengthen its legal framework to encourage new approaches that will increase the collection of plasma across Europe.Promoted content

Strengthening the EU Blood Directive for patients who need plasma-derived medicines
The revision of the European Union Blood, Tissues and Cells (BTC) Legislation brings an opportunity to strengthen its legal framework to encourage new approaches that will increase the collection of plasma across Europe.Promoted content

Europe needs to collect more plasma – Improving patient access to plasma-derived medicines
In the coming decade, it is expected that more European patients will need access to plasma-derived medicines.Promoted content
